ProQR Therapeutics N.V 20-F for FY2024
ProQR Therapeutics N.V. (PRQR)
20-F
2025-03-13
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 20-F
ProQR Therapeutics N.V filed this 20-F on March 13, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 18.91M EUR
- up 190.2% from 6.51M EUR a year earlier
- Net loss
- 27.76M EUR
- compared with a net loss of 28.12M EUR a year earlier
- Diluted EPS
- -0.32 EUR
- compared with -0.35 EUR a year earlier